Abstract
P-glycoprotein (Pgp)-mediated drug efflux is a major factor contributing to the variance of absorption and distribution of many drugs (Hall et al., 1999). A simple and reliable in vitro method to identify inhibitors of Pgp helps to prevent the potential of drug interactions. Using daunorubicin as a fluorescent marker and vanadate as a positive control compound, a functional flow cytometry method for assessing the ability of a drug to inhibit Pgp-mediated drug efflux from CR1R12 multidrug-resistant cells has been evaluated. Quantitation of the relative fluorescence was used to compare potency of individual inhibitors. Known Pgp inhibitors, such as cyclosporin A, nicardipine, verapamil, quinidine, terfenadine, tamoxifen, and vinblastine were demonstrated to inhibit the Pgp-mediated efflux of daunorubicin. Cyclosporin A and terfenadine were the most potent inhibitors among the compounds tested. Tetraphenylphosphonium and α-tocopherol had little inhibitory effect. Progesterone produced significant inhibition at relatively high concentrations. This study demonstrated that this in vitro flow cytometry method is a simple, sensitive, and quantitative tool to assess the capacity of a drug to inhibit Pgp transporters, and is useful for screening or identifying inhibitors of Pgp as well as evaluation of potential for drug interactions.
Footnotes
-
Send reprint requests to: William W. Johnson, Ph.D., 144 Route 94, P.O. Box 32, Schering-Plough Research Institute, Lafayette, NJ 07848-0032. E-mail: William.W.Johnson{at}spcorp.com
- Abbreviations used are::
- MDR
- multiple drug resistance
- DNR
- daunorubicin
- Pgp
- P-glycoprotein
- ABC
- ATP-binding cassette
- TPP
- tetraphenylphosphonium
- α-MEM
- α-minimum essential medium
- FBS
- fetal bovine serum
- Received September 8, 1999.
- Accepted January 28, 2000.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|